Vaxxinity reports fourth quarter and full-year 2021 financial results and provides corporate updates

Dallas, march 24, 2022 (globe newswire) -- vaxxinity, inc. (nasdaq: vaxx), a u.s. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended december 31, 2021.

VAXX Ratings Summary

VAXX Quant Ranking